ArticleFrontiers in oncology2024

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China.

Jinghong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.